Prolonged intra-myocardial growth hormone administration ameliorates post-infarction electrophysiologic remodeling in rats

References

• Agathopoulos S, Kolettis TM. 2014. Editorial: Novel strategies for cardiac repair post-myocardial infarction. Curr Pharm Des 20:1925–1929.
   PubMed Web of Science ®Google Scholar
• Aiba T, Tomaselli GF. 2010. Electrical remodeling in the failing heart. Curr Opin Cardiol 25:29–36.
   PubMed Web of Science ®Google Scholar
• Anker SD, Coats AJ, Cristian G, Dragomir D, Pusineri E, Piredda M, Bettari L, et al. 2015. A prospective comparison of alginate-hydrogel with standard medical therapy to determine impact on functional capacity and clinical outcomes in patients with advanced heart failure (AUGMENT-HF trial). Eur Heart J 36:2297–2309.
   PubMed Web of Science ®Google Scholar
• Arcopinto M, Bobbio E, Bossone E, Perrone-Filardi P, Napoli R, Sacca L, Cittadini A. 2013. The GH/IGF-1 axis in chronic heart failure. Endocr Metab Immune Disord Drug Targets 13:76–91.
   PubMed Web of Science ®Google Scholar
• Baudino TA, Carver W, Giles W, Borg TK. 2006. Cardiac fibroblasts: friend or foe? Am J Physiol Heart Circ Physiol 291:H1015–H1026.
   PubMed Web of Science ®Google Scholar
• Castagnino HE, Toranzos FA, Milei J, Weiss V, Beigelman R, Sarchi MI, Bordenave CA, Azcoaga R. 1992. Preservation of the myocardial collagen framework by human growth hormone in experimental infarctions and reduction in the incidence of ventricular aneurysms. Int J Cardiol 35:101–114.
   PubMed Web of Science ®Google Scholar
• Cittadini A, Grossman JD, Napoli R, Katz SE, Strömer H, Smith RJ, Clark R, et al. 1997. Growth hormone attenuates early left ventricular remodeling and improves cardiac function in rats with large myocardial infarction. J Am Coll Cardiol 29:1109–1116.
   PubMed Web of Science ®Google Scholar
• Curtis MJ, Hancox JC, Farkas A, Wainwright CL, Stables CL, Saint DA, Clements-Jewery H, et al. 2013. The Lambeth Conventions (II): Guidelines for the study of animal and human ventricular and supraventricular arrhythmias. Pharmacol Ther 139:213–248.
   PubMed Web of Science ®Google Scholar
• Daskalopoulos EP, Hermans KC, Blankesteijn WM. 2014. Cardiac (myo)fibroblast: Novel strategies for its targeting following myocardial infarction. Curr Pharm Des 20:1987–2002.
   PubMed Web of Science ®Google Scholar
• Daskalopoulos EP, Vilaeti AD, Barka E, Mantzouratou P, Kouroupis D, Kontonika M, Tourmousoglou C, et al. 2015. Attenuation of post-infarction remodeling in rats by sustained myocardial growth hormone administration. Growth Factors 33:250–258.
   PubMed Web of Science ®Google Scholar
• Elaiopoulos DA, Tsalikakis DG, Agelaki MG, Baltogiannis GG, Mitsi AC, Fotiadis DI, Kolettis TM. 2007. Growth hormone decreases phase II ventricular tachyarrhythmias during acute myocardial infarction in rats. Clin Sci (Lond) 112:385–391.
   PubMed Web of Science ®Google Scholar
• Frangogiannis NG. 2014. The inflammatory response in myocardial injury, repair, and remodelling. Nat Rev Cardiol 11:255–265.
   PubMed Web of Science ®Google Scholar
• Franz MR. 1999. Current status of monophasic action potential recording: Theories, measurements and interpretations. Cardiovasc Res 41:25–40.
   PubMed Web of Science ®Google Scholar
• Grant AO, Tranquillo J. 2007. Action potential and QT prolongation not sufficient to cause Torsade de Pointes: Role of action potential triangulation. J Cardiovasc Electrophysiol 18:204–205.
   PubMed Web of Science ®Google Scholar
• Harding JD, Piacentino V III, Gaughan JP, Houser SR, Margulies KB. 2001. Electrophysiological alterations after mechanical circulatory support in patients with advanced cardiac failure. Circulation 104:1241–1247.
   PubMed Web of Science ®Google Scholar
• Hardziyenka M, Campian ME, Tan HL. 2007. Right ventricular failure: electrophysiological remodeling in right ventricle precedes clinical signs (abstract). Eur J Heart Fail Suppl 6:87
   Google Scholar
• Hatzistergos KE, Mitsi AC, Zachariou C, Skyrlas A, Kapatou E, Agelaki MG, Fotopoulos A, et al. 2008. Randomised comparison of growth hormone versus IGF-1 on early post-myocardial infarction ventricular remodelling in rats. Growth Horm IGF Res 18:157–165.
   PubMed Web of Science ®Google Scholar
• Hondeghem LM, Carlsson L, Duker G. 2001. Instability and triangulation of the action potential predict serious proarrhythmia, but action potential duration prolongation is antiarrhythmic. Circulation 103:2004–2013.
   PubMed Web of Science ®Google Scholar
• Jayasankar V, Pirolli TJ, Bish LT, Berry MF, Burdick J, Grand T, Woo YJ. 2004. Targeted overexpression of growth hormone by adenoviral gene transfer preserves myocardial function and ventricular geometry in ischemic cardiomyopathy. J Mol Cell Cardiol 36:531–538.
   PubMed Web of Science ®Google Scholar
• Jin H, Yang R, Lu H, Ogasawara AK, Li W, Ryan A, Peale F, Paoni NF. 2002. Effects of early treatment with growth hormone on infarct size, survival, and cardiac gene expression after acute myocardial infarction. Growth Horm IGF Res 12:208–215.
   PubMed Web of Science ®Google Scholar
• Kleber AG, Rudy Y. 2004. Basic mechanisms of cardiac impulse propagation and associated arrhythmias. Physiol Rev 84:431–488.
   PubMed Web of Science ®Google Scholar
• Kolettis TM, La Rocca V, Psychalakis N, Karampela E, Kontonika M, Tourmousoglou C, Baltogiannis GG, et al. 2016. Effects of central sympathetic activation on repolarization–dispersion during short-term myocardial ischemia in anesthetized rats. Life Sci 144:170–177.
   PubMed Web of Science ®Google Scholar
• Kolettis TM. 2006. Arrhythmogenesis after cell transplantation post-myocardial infarction. Four burning questions- and some answers. Cardiovasc Res 69:299–301.
   PubMed Web of Science ®Google Scholar
• Kolettis TM. 2013. Coronary artery disease and ventricular tachyarrhythmia: Pathophysiology and treatment. Curr Opin Pharmacol 13:210–217.
   PubMed Web of Science ®Google Scholar
• Kontonika M, Barka E, Roumpi M, Vilaeti AD, Baltogiannis GG, Vlahos AP, Agathopoulos S, Kolettis TM. 2016. Intra-myocardial growth hormone administration ameliorates arrhythmogenesis during ischemia-reperfusion in rats. J Electrocardiol. [Epub ahead of print]. doi: 10.1016/j.jelectrocard.2016.10.004
   PubMed Web of Science ®Google Scholar
• Landa N, Miller L, Feinberg MS, Holbova R, Shachar M, Freeman I, Cohen S, Leor J. 2008. Effect of injectable alginate implant on cardiac remodeling and function after recent and old infarcts in rat. Circulation 117:1388–1396.
   PubMed Web of Science ®Google Scholar
• Li GR, Sun HY, Chen JB, Zhou Y, Tse HF, Lau CP. 2009. Characterization of multiple ion channels in cultured human cardiac fibroblasts. PLoS One 4:e7307.
   PubMed Web of Science ®Google Scholar
• Marmor A, Geltman EM, Biello DR, Sobel BE, Siegel BA, Roberts R. 1981. Functional response of the right ventricle to myocardial infarction: Dependence of the site of left ventricular infarction. Circulation 64:1005–1011.
   PubMed Web of Science ®Google Scholar
• Mitsi AC, Hatzistergos K, Baltogiannis GG, Kolettis TM. 2005. Early, selective growth hormone administration may ameliorate left ventricular remodeling after myocardial infarction. Med Hypotheses 64:582–585.
   PubMed Web of Science ®Google Scholar
• Mitsi AC, Hatzistergos KE, Niokou D, Pappa L, Baltogiannis GG, Tsalikakis DG, Papalois A, et al. 2006. Early, intracoronary growth hormone administration attenuates ventricular remodeling in a porcine model of myocardial infarction. Growth Horm IGF Res 16:93–100.
   PubMed Web of Science ®Google Scholar
• Molina EJ, Palma J, Gupta D, Gaughan JP, Houser S, Macha M. 2009. Right ventricular effects of intracoronary delivery of mesenchymal stem cells (MSC) in an animal model of pressure overload heart failure. Biomed Pharmacother 63:767–772.
   PubMed Web of Science ®Google Scholar
• Mueller EE, Momen A, Masse S, Zhou YQ, Liu J, Backx PH, Henkelman RM, et al. 2011. Electrical remodelling precedes heart failure in an endothelin-1-induced model of cardiomyopathy. Cardiovasc Res 89:623–633.
   PubMed Web of Science ®Google Scholar
• Oikonomidis DL, Tsalikakis DG, Baltogiannis GG, Tzallas AT, Xourgia X, Agelaki MG, Megalou AJ, et al. 2010. Endothelin-B receptors and ventricular arrhythmogenesis in the rat model of acute myocardial infarction. Basic Res Cardiol 105:235–245.
   PubMed Web of Science ®Google Scholar
• Opitz CF, Mitchell GF, Pfeffer MA, Pfeffer JM. 1995. Arrhythmias and death after coronary artery occlusion in the rat. Continuous telemetric ECG monitoring in conscious, untethered rats. Circulation 92:253–261.
   PubMed Web of Science ®Google Scholar
• Pinto JM, Boyden PA. 1999. Electrical remodeling in ischemia and infarction. Cardiovasc Res 42:284–297.
   PubMed Web of Science ®Google Scholar
• Pu J, Boyden PA. 1997. Alterations of Na+ currents in myocytes from epicardial border zone of the infarcted heart. A possible ionic mechanism for reduced excitability and postrepolarization refractoriness. Circ Res 81:110–119.
   PubMed Web of Science ®Google Scholar
• Rajagopalan N, Suffoletto MS, Tanabe M, Miske G, Thomas NC, Simon MA, Bazaz R, et al. 2007. Right ventricular function following cardiac resynchronization therapy. Am J Cardiol 100:1434–1436.
   PubMed Web of Science ®Google Scholar
• Råmunddal T, Gizurarson S, Lorentzon M, Omerovic E. 2008. Antiarrhythmic effects of growth hormone – in vivo evidence from small-animal models of acute myocardial infarction and invasive electrophysiology. J Electrocardiol 41:144–148.
   PubMed Web of Science ®Google Scholar
• Rao SV, Zeymer U, Douglas PS, Al-Khalidi H, White JA, Liu J, Levy H, et al. 2016. Bioabsorbable intracoronary matrix for prevention of ventricular remodeling after myocardial infarction. J Am Coll Cardiol 68:715–723.
   PubMed Web of Science ®Google Scholar
• Sun Y, Zhang JQ, Zhang J, Lamparter S. 2000. Cardiac remodeling by fibrous tissue after infarction in rats. J Lab Clin Med 135:316–323.
   PubMed Web of Science ®Google Scholar
• Turner NA, Porter KE. 2013. Function and fate of myofibroblasts after myocardial infarction. Fibrogenesis Tissue Repair 6:5.
   PubMedGoogle Scholar
• Ueyama T, Ohkusa T, Yano M, Matsuzaki M. 1998. Growth hormone preserves cardiac sarcoplasmic reticulum Ca2+ release channels (ryanodine receptors) and enhances cardiac function in cardiomyopathic hamsters. Cardiovasc Res 40:64–73.
   PubMed Web of Science ®Google Scholar
• Yang R, Bunting S, Gillett N, Clark R, Jin H. 1995. Growth hormone improves cardiac performance in experimental heart failure. Circulation 92:262–267.
   PubMed Web of Science ®Google Scholar
• Zhang D, Chai S, Chen M, Wu A, Lou L, Zhao M, Gao Y, et al. 2016. The correlation between ventricular remodeling and arrhythmia in rat with myocardial infarction. Int J Clin Exp Med 9:1986–1996.
   Web of Science ®Google Scholar